NARDONE, Valerio
 Distribuzione geografica
Continente #
EU - Europa 7.232
NA - Nord America 4.129
AS - Asia 3.450
SA - Sud America 519
Continente sconosciuto - Info sul continente non disponibili 281
AF - Africa 38
OC - Oceania 7
Totale 15.656
Nazione #
RU - Federazione Russa 5.253
US - Stati Uniti d'America 3.922
SG - Singapore 1.246
IT - Italia 757
IE - Irlanda 716
CN - Cina 677
HK - Hong Kong 591
BR - Brasile 437
VN - Vietnam 417
KR - Corea 192
DE - Germania 161
GB - Regno Unito 98
IN - India 95
CA - Canada 74
JP - Giappone 64
BD - Bangladesh 46
NL - Olanda 40
AT - Austria 36
FR - Francia 28
MX - Messico 26
AR - Argentina 25
CR - Costa Rica 25
FI - Finlandia 24
GR - Grecia 19
BE - Belgio 16
EC - Ecuador 15
IQ - Iraq 15
PL - Polonia 15
PK - Pakistan 14
ID - Indonesia 13
TR - Turchia 13
ZA - Sudafrica 13
CO - Colombia 12
NI - Nicaragua 12
CZ - Repubblica Ceca 11
HN - Honduras 11
SV - El Salvador 11
UA - Ucraina 11
UZ - Uzbekistan 10
VE - Venezuela 10
ES - Italia 9
PR - Porto Rico 9
SE - Svezia 9
GT - Guatemala 8
JM - Giamaica 8
SA - Arabia Saudita 8
IR - Iran 7
PE - Perù 7
MA - Marocco 6
TT - Trinidad e Tobago 6
CL - Cile 5
EG - Egitto 5
KZ - Kazakistan 5
OM - Oman 5
UY - Uruguay 5
AU - Australia 4
CH - Svizzera 4
DK - Danimarca 4
IL - Israele 4
LT - Lituania 4
RO - Romania 4
BO - Bolivia 3
BS - Bahamas 3
EE - Estonia 3
GP - Guadalupe 3
JO - Giordania 3
PA - Panama 3
PH - Filippine 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
DZ - Algeria 2
KE - Kenya 2
LK - Sri Lanka 2
MY - Malesia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HT - Haiti 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 15.364
Città #
Moscow 1.907
Dublin 716
San Jose 659
Santa Clara 596
Hong Kong 582
Singapore 520
Ashburn 417
Council Bluffs 324
Seoul 192
Chandler 168
Hefei 153
Ho Chi Minh City 125
Naples 119
Hanoi 112
Milan 112
Dallas 100
Beijing 99
Princeton 92
Roxbury 74
The Dalles 69
Bremen 61
Bengaluru 60
Cambridge 58
New York 49
Los Angeles 42
São Paulo 42
Munich 38
Jacksonville 33
Dong Ket 26
Rome 24
Da Nang 22
San José 22
Phoenix 21
Nuremberg 19
Miano 18
Orem 18
Rio de Janeiro 18
Atlanta 17
Brussels 16
Medford 16
Boardman 15
North Bergen 15
Amsterdam 14
Falkenstein 14
Vienna 14
Aversa 13
Belo Horizonte 13
Des Moines 13
Florence 13
Frankfurt am Main 13
Tokyo 13
Haiphong 12
Managua 12
Newark 12
Brooklyn 11
Buffalo 11
Chicago 11
Helsinki 11
Hillsboro 11
San Salvador 11
Warsaw 10
Brno 9
Hải Dương 9
Kochi 9
Memphis 9
Mexico City 9
Montreal 9
Tashkent 9
Bologna 8
Bắc Ninh 8
Campinas 8
Goiânia 8
Lappeenranta 8
Miami 8
Seattle 8
Toronto 8
Ann Arbor 7
Bari 7
Chennai 7
Denver 7
Dhaka 7
Johannesburg 7
London 7
Manchester 7
Shanghai 7
Boston 6
Brasília 6
Charlotte 6
Curitiba 6
Genoa 6
Guatemala City 6
Hangzhou 6
Kingston 6
San Francisco 6
San Juan 6
Solofra 6
Stockholm 6
Thái Bình 6
Tianjin 6
Turin 6
Totale 8.298
Nome #
A trimodality, four-step treatment including chemotherapy, pleurectomy/decortication and radiotherapy in early-stage malignant pleural mesothelioma: A single-institution retrospective case series study 199
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 198
Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy 181
Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery 180
Delta radiomics: a systematic review 172
CARdioimaging in Lung Cancer PatiEnts Undergoing Radical RadioTherapy: CARE-RT Trial 171
Recurrent Versus Metastatic Head and Neck Cancer: An Evolving Landscape and the Role of Immunotherapy 164
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 163
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial 163
MRI Radiomics in Prostate Cancer: A Reliability Study 161
Secondary Complications in COVID-19 Patients: A Case Series 160
4D CT analysis of organs at risk (OARs) in stereotactic radiotherapy 160
Radiomics as a new frontier of imaging for cancer prognosis: A narrative review 160
Diffusion-weighted imaging and apparent diffusion coefficient mapping of head and neck lymph node metastasis: a systematic review 157
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 156
"RT STRIKES BACK": Radiotherapy in Ultra Elderly with Cutaneous Basal Cell Carcinoma 149
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 149
Non-Oncological Radiotherapy: A Review of Modern Approaches 148
Quantitative Evaluation of the Lymph Node Metastases in the Head and Neck Malignancies Using Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Mapping: A Bicentric Study 147
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study 146
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 146
Delta-radiomics increases multicentre reproducibility: a phantom study 144
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 142
Identification of perineural invasion at imaging staging as a novel potential risk factor in rectal cancer: A case report 140
Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: A retrospective analysis 137
Artificial intelligence applied to image-guided radiation therapy (IGRT): a systematic review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 137
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 137
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy 137
Management of Non-Melanoma Skin Cancer: Radiologists Challenging and Risk Assessment 137
Diagnostic Value of Contrast-Enhanced Ultrasound in Differentiating Malignant from Benign Small Renal Masses After CT/MRI 136
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 135
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 134
Artificial intelligence and radiation effects on brain tissue in glioblastoma patient: preliminary data using a quantitative tool 133
Robustness of Radiomics in Pre-Surgical Computer Tomography of Non-Small-Cell Lung Cancer 133
Total Severity Score (TSS) comparison in vaccinated and unvaccinated patients during the fourth wave (December 2021 - January 2022) of COVID-19 in Italy 128
Nuclear medicine and radiotherapy in the clinical management of glioblastoma patients 128
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology 126
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk 126
Advances in traditional Chinese herbal medicine and their pharmacodynamic mechanisms in cancer immunoregulation: a narrative review 125
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of “difficult to treat” non melanoma skin cancer 125
A critical review on oligometastatic disease: a radiation oncologist’s perspective 125
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures 125
Abemaciclib for malignant pleural mesothelioma 124
Genetic profiling in radiotherapy: a comprehensive review 124
Choosing the optimal gated window for defining target volume in lung stereotactic ablative radiotherapy 123
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 122
Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy 120
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC 119
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 119
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 118
Are you planning to be a radiation oncologist? A survey by the young group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 117
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 117
Pitfalls and differential diagnosis on adrenal lesions: current concepts in CT/MR imaging: a narrative review 115
“Aging and epigenetic implications in radiotherapy: The promise of BNCT” 115
Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensus 112
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 112
Prognostic Value of Sarcopenia in Elderly Patients with Metastatic Non-Small-Cell Lung Cancer Undergoing Radiotherapy 112
Feasibility of stereotactic ablative reirradiation in breast cancer patient undergoing palbociclib: A case report 111
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 109
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: A role for autophagy 108
Magnetic-Resonance-Imaging Texture Analysis Predicts Early Progression in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiation 107
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 107
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 106
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 105
Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients 105
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 104
Temporal muscle thickness and survival in patients with amyotrophic lateral sclerosis 102
Texture Analysis in Cancer Prognosis 102
The role of coronary artery calcification score in lung cancer patients 102
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 102
Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma 101
Delayed enhancement in differential diagnosis of salivary gland neoplasm 101
Effects of CT FOV displacement and acquisition parameters variation on texture analysis features 101
Putative role of circulating human papillomavirus DNA in the development of primary squamous cell carcinoma of the middle rectum: a case report 99
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 98
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 97
ESTRO vision 2030: the young Italian Association of Radiotherapy and Clinical Oncology (yAIRO) commitment statement 96
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 96
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 96
Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal End Point? 94
Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature? 93
Mood Disorder in Cancer Patients Undergoing Radiotherapy During the COVID-19 Outbreak 93
Could PD-1/PDL1 immune checkpoints be linked to HLA signature? 92
The texture analysis as a predictive method in the assessment of the cytological specimen of CT-guided FNAC of the lung cancer 92
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 92
The role of radiation therapy and systemic therapies in elderly with breast cancer 92
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation 91
Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases 90
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? 90
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 90
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 90
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 88
Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung Cancer 88
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 87
Lumbosacral Plexopathy in Pelvic Radiotherapy: An Association not to be Neglected; A Systematic Review 87
Magnetic Resonance Imaging Evaluation of Bone Metastases Treated with Radiotherapy in Palliative Intent: A Multicenter Prospective Study on Clinical and Instrumental Evaluation Assessment Concordance (MARTE Study) 87
Preliminary Experience in Ultra-High Frequency Ultrasound Assessment of Cutaneous Primary Lymphomas: An Innovative Classification 86
Does multiparametric US improve diagnostic accuracy in the characterization of small testicular masses? 86
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 86
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 86
Totale 12.124
Categoria #
all - tutte 57.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022401 0 0 0 1 46 6 50 21 11 76 30 160
2022/20231.041 83 11 31 52 108 52 19 51 575 8 32 19
2023/2024570 39 29 26 36 202 32 18 16 15 6 46 105
2024/20252.424 12 52 34 74 376 352 322 222 332 343 153 152
2025/20269.150 339 504 466 395 742 4.868 502 450 388 254 151 91
2026/20271.891 66 283 649 893 0 0 0 0 0 0 0 0
Totale 15.656